Journal of Patient Safety.21(1):35-37, January 2025. Abstract PDF Permissions Buy Letter to the Editor Cross-disciplinary Insights for Overcoming Speak-up Barriers in Medical Education Jerjes, Waseem Journal of Patient Safety.21(1):e1-e2, January 2025. ...
Anis unavailable. This article is available as HTML full text and PDF.doi:10.1097/01209203-200506000-00002ClancyCarolyn M.Journal of Patient SafetyClancy CM. An ongoing discussion with the readers of the Journal of Patient Safety . J Patient Saf. 2005; 1 :76–77....
December 2024View PDF Research articleOpen access Determination of Medical Faculty Clinical Students' Attitudes Towards Patient Safety: A Mixed Design Study Yasemin Güner, ... Tuğçe MüminDecember 2024View PDF Research articleOpen access Asthma Among Manitoba Workers: Results from the Manitoba ...
Patient safety of virtual primary care: A qualitative study examining risks and mitigation strategies Olivia Lounsbury, ... Ana Luisa Neves February 2025View PDF Research articleOpen access Development of the FitBack online platform: Enhancing global child fitness assessment, health-related interpretation,...
Nurses were asked to respond to adverse respiratory events with an intervention to improve the patient’s respiratory condition. There was no difference in the number of patients that experienced at least one adverse respiratory event: 21 and 16 in observational and interventional group, respectively ...
Journal of Integrative Medicine. 2024,22(6): 621-636. doi:10.1016/j.joim.2024.09.003 Abstract ( 44 ) HTML PDF Related Articles | Metrics Original Clinical Research Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19:...
We assessed health-related quality of life (symptoms of therapy/patient functioning/global health status), in APHINITY (pertuzumab/placebo, trastuzumab, and chemotherapy as adjuvant HER2-positive early breast cancer therapy). Patients received 1 year/18
Atacicept is an inhibitor of the B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), and is being studied in relation to immunologi
JOURNAL OF REPRODUCTION AND CONTRACEPTION (Original title: Reproduction and Contraception) Monthly Established in December 1980 Volume 37, Number 4 April 25, 2017 Responsible Institution Sponsor Chinese Medical Association, Shanghai Institute of Planned Parenthood Research, Gynecological and Obstetrical ...
safety and efficacy information from their pivotal trials. There is an increased interest among patients and healthcare providers to understand the patient experience with these novel therapies. One way to measure the patient experience in oncology clinical trials is through the use of patient-reported...